Clinical identification and microbiota analysis of Chlamydia psittaci- and Chlamydia abortus- pneumonia by metagenomic next-generation sequencing

Introduction Recently, the incidence of chlamydial pneumonia caused by rare pathogens such as C. psittaci or C. abortus has shown a significant upward trend. The non-specific clinical manifestations and the limitations of traditional pathogen identification methods determine that chlamydial pneumonia is likely to be poorly diagnosed or even misdiagnosed, and may further result in delayed treatment or unnecessary antibiotic use. mNGS's non-preference and high sensitivity give us the opportunity to obtain more sensitive detection results than traditional methods for rare pathogens such as C. psittaci or C. abortus. Methods In the present study, we investigated both the pathogenic profile characteristics and the lower respiratory tract microbiota of pneumonia patients with different chlamydial infection patterns using mNGS. Results More co-infecting pathogens were found to be detectable in clinical samples from patients infected with C. psittaci compared to C. abortus, suggesting that patients infected with C. psittaci may have a higher risk of mixed infection, which in turn leads to more severe clinical symptoms and a longer disease course cycle. Further, we also used mNGS data to analyze for the first time the characteristic differences in the lower respiratory tract microbiota of patients with and without chlamydial pneumonia, the impact of the pattern of Chlamydia infection on the lower respiratory tract microbiota, and the clinical relevance of these characteristics. Significantly different profiles of lower respiratory tract microbiota and microecological diversity were found among different clinical subgroups, and in particular, mixed infections with C. psittaci and C. abortus resulted in lower lung microbiota diversity, suggesting that chlamydial infections shape the unique lung microbiota pathology, while mixed infections with different Chlamydia may have important effects on the composition and diversity of the lung microbiota. Discussion The present study provides possible evidences supporting the close correlation between chlamydial infection, altered microbial diversity in patients' lungs and clinical parameters associated with infection or inflammation in patients, which also provides a new research direction to better understand the pathogenic mechanisms of pulmonary infections caused by Chlamydia.

[1]  Ziwen Zhao,et al.  Clinical and chest computed tomography features associated with severe Chlamydia psittaci pneumonia diagnosed by metagenomic next-generation sequencing: A multicenter, retrospective, observational study , 2022, Medicine.

[2]  M. Aguirre-García,et al.  Overexpression of proinflammatory cytokines in dental pulp tissue and distinct bacterial microbiota in carious teeth of Mexican Individuals , 2022, Frontiers in Cellular and Infection Microbiology.

[3]  L. Segal,et al.  The dynamic lung microbiome in health and disease , 2022, Nature Reviews Microbiology.

[4]  M. Noursadeghi,et al.  Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults , 2022, The Journal of infection.

[5]  F. Chen,et al.  Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study , 2022, Frontiers in Cellular and Infection Microbiology.

[6]  Jinwei Huang,et al.  Severe community-acquired pneumonia caused by Chlamydia psittaci genotype E/B strain circulating among geese in Lishui city, Zhejiang province, China , 2022, Emerging microbes & infections.

[7]  Chen Zhao,et al.  Alterations in the gut microbiota of AIDS patients with pneumocystis pneumonia and correlations with the lung microbiota , 2022, Frontiers in Cellular and Infection Microbiology.

[8]  Tingyan Dong,et al.  Clinical diagnosis and etiology of patients with Chlamydia psittaci pneumonia based on metagenomic next-generation sequencing , 2022, Frontiers in Cellular and Infection Microbiology.

[9]  Lin Gao,et al.  Clinical value of metagenomic next-generation sequencing by Illumina and Nanopore for the detection of pathogens in bronchoalveolar lavage fluid in suspected community-acquired pneumonia patients , 2022, Frontiers in Cellular and Infection Microbiology.

[10]  W. Shi,et al.  Host inflammatory response is the major factor in the progression of Chlamydia psittaci pneumonia , 2022, Frontiers in Immunology.

[11]  Bin Chen,et al.  Effect of invasive mechanical ventilation on the diversity of the pulmonary microbiota , 2022, Critical Care.

[12]  Ganzhu Feng,et al.  Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study , 2022, Microbiology spectrum.

[13]  Huan Xu,et al.  Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pneumonia Caused by Chlamydia psittaci , 2022, Microbiology spectrum.

[14]  Peng Hu,et al.  Targeted Next Generation Sequencing is Comparable with Metagenomic Next Generation Sequencing in Adults with Pneumonia for Pathogenic Microorganism Detection. , 2022, The Journal of infection.

[15]  P. Póvoa,et al.  Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia , 2022, Critical Care.

[16]  Haoyi Wang,et al.  Atypical pneumonia caused by Chlamydia psittaci during the COVID-19 pandemic , 2022, International Journal of Infectious Diseases.

[17]  Shuizi Ding,et al.  Clinical Characteristics of Chlamydia psittaci Pneumonia Infection in Central South China , 2022, Infectious Diseases and Therapy.

[18]  Bin Liu,et al.  The Application Value of Metagenomic and Whole-Genome Capture Next-Generation Sequencing in the Diagnosis and Epidemiological Analysis of Psittacosis , 2022, Frontiers in Cellular and Infection Microbiology.

[19]  K. Kammoun,et al.  Acinetobacter lwoffi peritonitis in peritoneal dialysis: two cases report , 2022, La Tunisie medicale.

[20]  Hongke Zeng,et al.  Septic shock with Chlamydia abortus infection. , 2022, The Lancet. Infectious diseases.

[21]  E. Holmes,et al.  Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation. , 2022, The Lancet. Microbe.

[22]  Hui Wang,et al.  Association Among the Gut Microbiome, the Serum Metabolomic Profile and RNA m6A Methylation in Sepsis-Associated Encephalopathy , 2022, Frontiers in Genetics.

[23]  H. Marti,et al.  Animal Chlamydiae: A Concern for Human and Veterinary Medicine , 2022, Pathogens.

[24]  Guoliang Zhang,et al.  Insights into the Unique Lung Microbiota Profile of Pulmonary Tuberculosis Patients Using Metagenomic Next-Generation Sequencing , 2022, Microbiology spectrum.

[25]  T. Gao,et al.  Bloodstream infection and pneumonia caused by Chlamydia abortus infection in China: a case report , 2022, BMC Infectious Diseases.

[26]  Jinglong Chen,et al.  Characteristics of Lung Microbiota in Children's Refractory Mycoplasma pneumoniae Pneumonia Coinfected with Human Adenovirus B , 2022, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[27]  Wei Liu,et al.  Comparison of the respiratory tract microbiome in hospitalized COVID‐19 patients with different disease severity , 2022, Journal of medical virology.

[28]  S. Albini,et al.  Zoonotic Chlamydiae as rare causes of severe pneumonia. , 2022, Swiss medical weekly.

[29]  J. Cassat,et al.  Metabolic Adaptations During Staphylococcus aureus and Candida albicans Co-Infection , 2021, Frontiers in Immunology.

[30]  Sang-Heon Cho,et al.  Effect of Acinetobacter lwoffii on the modulation of macrophage activation and asthmatic inflammation , 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  Lan-fang Feng,et al.  Application of metagenomic next-generation sequencing in the diagnosis of severe pneumonia caused by Chlamydia psittaci , 2021, BMC pulmonary medicine.

[32]  Tao Ding,et al.  Pathogen Metagenomics Reveals Distinct Lung Microbiota Signatures Between Bacteriologically Confirmed and Negative Tuberculosis Patients , 2021, Frontiers in Cellular and Infection Microbiology.

[33]  T. Gabaldón,et al.  Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients , 2021, Thorax.

[34]  Xiangyin Kong,et al.  Characterization of the Blood and Cerebrospinal Fluid Microbiome in Children with Bacterial Meningitis and Its Potential Correlation with Inflammation , 2021, mSystems.

[35]  M. Antonelli,et al.  Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis , 2021, Critical Care.

[36]  Zujiang Yu,et al.  Metagenomic next-generation sequencing clinches diagnosis of leishmaniasis , 2021, The Lancet.

[37]  Dao-xin Wang,et al.  Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19 , 2021, Emerging microbes & infections.

[38]  Bijie Hu,et al.  High‐Throughput Metagenomics for Identification of Pathogens in the Clinical Settings , 2020, Small methods.

[39]  Shuangquan Liu,et al.  Chlamydia psittaci Plasmid-Encoded CPSIT_P7 Elicits Inflammatory Response in Human Monocytes via TLR4/Mal/MyD88/NF-κB Signaling Pathway , 2020, Frontiers in Microbiology.

[40]  M. Szymańska-Czerwińska,et al.  Chlamydiae – What’s New? , 2020, Journal of veterinary research.

[41]  J. Derisi,et al.  Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids , 2020, Nature Medicine.

[42]  M. Vasson,et al.  Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial , 2020, Respiratory Research.

[43]  Qin Gu,et al.  Metagenomic next-generation sequencing in the diagnosis of severe pneumonias caused by Chlamydia psittaci , 2020, Infection.

[44]  Minjin Wang,et al.  International Expansion of a Novel SARS-CoV-2 Mutant , 2020, Journal of Virology.

[45]  J. E. Muñoz-Medina,et al.  Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance , 2020, Nature Microbiology.

[46]  Xinchun Chen,et al.  Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study , 2020, Emerging microbes & infections.

[47]  C. Szablewski,et al.  Psittacosis Outbreak among Workers at Chicken Slaughter Plants, Virginia and Georgia, USA, 2018 , 2019, Emerging infectious diseases.

[48]  W. Wong,et al.  Chlamydiaceae: Diseases in Primary Hosts and Zoonosis , 2019, Microorganisms.

[49]  E. Sanders,et al.  Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study , 2019, The Lancet Respiratory Medicine.

[50]  Jane C. Deng,et al.  Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia , 2018, Front. Immunol..

[51]  Xiaolin Xu,et al.  Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  F. Eko,et al.  Chlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways , 2017, Front. Cell. Infect. Microbiol..

[53]  S. Barati,et al.  The role of zoonotic chlamydial agents in ruminants abortion , 2017, Iranian journal of microbiology.

[54]  Wouter A. A. de Steenhuijsen Piters,et al.  The microbiota of the respiratory tract: gatekeeper to respiratory health , 2017, Nature Reviews Microbiology.

[55]  M. R. Caro,et al.  Isolation of Chlamydia abortus from a laboratory worker diagnosed with atypical pneumonia , 2016, Irish Veterinary Journal.

[56]  N. Singh,et al.  Pyogenic Liver Abscess Caused by Acinetobacter lwoffii: A Case Report. , 2016, Journal of clinical and diagnostic research : JCDR.

[57]  Sandeep J. Joseph,et al.  Chlamydiaceae Genomics Reveals Interspecies Admixture and the Recent Evolution of Chlamydia abortus Infecting Lower Mammalian Species and Humans , 2015, Genome biology and evolution.

[58]  M. Horn,et al.  Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species. , 2015, Systematic and applied microbiology.

[59]  A. Wallensten,et al.  Multiple human-to-human transmission from a severe case of psittacosis, Sweden, January-February 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[60]  M. Nieuwdorp,et al.  Role of the microbiome in energy regulation and metabolism. , 2014, Gastroenterology.

[61]  P. Hemarajata,et al.  The human gut microbiome and body metabolism: implications for obesity and diabetes. , 2013, Clinical chemistry.

[62]  N. Wheelhouse,et al.  Endemic and emerging chlamydial infections of animals and their zoonotic implications. , 2012, Transboundary and emerging diseases.

[63]  K. Chida,et al.  Fulminant community‐acquired pneumonia probably caused by Acinetobacter lwoffii , 2010, Respirology.

[64]  G. Myers,et al.  Divergence without difference: phylogenetics and taxonomy of Chlamydia resolved. , 2009, FEMS immunology and medical microbiology.

[65]  T. Harkinezhad,et al.  Chlamydophila psittaci genotype E/B transmission from African grey parrots to humans. , 2007, Journal of medical microbiology.

[66]  Gilbert GREUB,et al.  Pathogenic Potential of Novel Chlamydiae and Diagnostic Approaches to Infections Due to These Obligate Intracellular Bacteria , 2006, Clinical Microbiology Reviews.

[67]  D. Corsaro,et al.  Emerging Chlamydial Infections , 2004, Critical reviews in microbiology.

[68]  A. Pospischil,et al.  Abort beim Menschen durch Chlamydophila abortus (Chlamydia psittaci serovar 1) , 2002 .

[69]  A. Ray,et al.  Respiratory tract microbiome and pneumonia. , 2022, Progress in molecular biology and translational science.